CIK: 0001542339
Total reported value
$250.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABMDEUR | Abiomed INC | Stock-Other | 37.26% | — | — | |
| 2 | RVNCEUR | Revance Therapeutics INC | Stock-Other | 21.68% | — | — | |
| 3 | ✓ | Entellus Medical INC | Stock-Other | 16.50% | — | — | |
| 4 | AXGN | Axogen INC | Stock-Other | 9.98% | — | — | |
| 5 | ✓ | Corium Intl INC | Stock-Other | 8.66% | — | — | |
| 6 | ✓ | Endologix INC | Stock-Other | 3.24% | — | — | |
| 7 | MNOV | Medicinova INC | Stock-Other | 1.61% | +0.14% | — | |
| 8 | LGND | Ligand Pharmaceuticals | Stock-Healthcare | 0.55% | — | — | |
| 9 | ACUR | Acura Pharmaceuticals INC | Stock-Other | 0.34% | — | — | |
| 10 | ✓ | Catalyst Biosciences INC | Stock-Other | 0.18% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RVNCEUR | Revance Therapeutics INC | +6.2% | — | Unchanged |
| 2 | AXGN | Axogen INC | +0.9% | — | Unchanged |
| 3 | LGND | Ligand Pharmaceuticals | +0.1% | — | Unchanged |
| 4 | ✓ | Catalyst Biosciences INC | -0.1% | — | Unchanged |
| 5 | MNOV | Medicinova INC | -0.2% | — | Unchanged |
| 6 | ACUR | Acura Pharmaceuticals INC | -0.3% | — | Unchanged |
| 7 | ✓ | Entellus Medical INC | -1.1% | — | Unchanged |
| 8 | ✓ | Endologix INC | -1.5% | — | Unchanged |
| 9 | ABMDEUR | Abiomed INC | -1.5% | — | Unchanged |
| 10 | ✓ | Corium Intl INC | -2.3% | — | Unchanged |